Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FD8VN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,523
Award facts
- Contract value 100% obligated
- $16,523.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,523.42 for KESIMPTA 20 mg/0.4 ml pen pharmaceutical supplies. This non-set-aside, competitively awarded contract employs firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
This delivery order represents a routine fulfillment of the broader pharmaceutical support vehicle that enables AmerisourceBergen to supply medications and medical supplies to military healthcare systems worldwide. KESIMPTA is a specialty pharmaceutical product used in the treatment of multiple sclerosis, reflecting the company's established portfolio of neurological medications and specialized healthcare commodities. As a critical vendor within the DLA's Medical Supply Chain, AmerisourceBergen continues to support Defense Health Agency requirements and other federal healthcare systems through its comprehensive IDC arrangement, which encompasses brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FD8VN?
SPE2DB25FD8VN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FD8VN worth?
The government has obligated $16,523 on SPE2DB25FD8VN.
Is contract SPE2DB25FD8VN an order under another contract?
Yes. SPE2DB25FD8VN is a delivery order under SPE2DB20D1051, an indefinite delivery contract.
Was contract SPE2DB25FD8VN competed?
The extent of competition for SPE2DB25FD8VN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award